A Clinical Study of Enlicitide Decanoate in People With Liver Function Problems (MK-0616-030)

Clinical trial NCT06575959 · COMPLETED

Trial details

NCT number: NCT06575959
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Insufficiency Hepatic Impairment

Start date: 2024-09-20
Primary completion: 2025-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.